Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$717M in Q1 2015 → $656M now. Hover for any quarter.
As reported for the quarter ended December 31, 2015. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| CC Celgene Corporation | 4.0% | Trimmed 5.4% | 217,410 | $26M |
| Biogen Inc. | 3.9% | Added 17% | 84,030 | $25.7M |
| Gilead Sciences, Inc. | 3.7% | Trimmed 5.5% | 240,120 | $24.3M |
| Amgen Inc. | 3.0% | Added 2.5% | 123,000 | $20M |
| Regeneron Pharmaceuticals, Inc. | 3.0% | Trimmed 6.4% | 36,400 | $19.8M |
| Medtronic, Inc. | 3.0% | Trimmed 5.0% | 256,500 | $19.7M |
| Illumina, Inc. | 2.7% | Added 4.3% | 91,425 | $17.5M |
| Abbott Laboratories | 2.6% | Trimmed 18% | 381,500 | $17.1M |
| M Mylan Inc. | 2.6% | Added 40% | 315,300 | $17M |
| Becton, Dickinson And Company | 2.5% | Added 14% | 105,075 | $16.2M |
| Cardinal Health, Inc. | 2.3% | Added 114% | 171,480 | $15.3M |
| Unitedhealth Group Incorporated | 2.2% | Unchanged | 120,000 | $14.1M |
| Stryker Corporation | 2.0% | Unchanged | 140,700 | $13.1M |
| TP Teva Pharmaceuticals, Inc. | 1.8% | Added 4.4% | 176,720 | $11.6M |
| ES Express Scripts Holding Company | 1.7% | Trimmed 23% | 124,000 | $10.8M |
| Endo International PLC | 1.6% | Added 8.2% | 171,000 | $10.5M |
| AM Auris Medical Holding Ag | 1.6% | Unchanged | 2,169,625 | $10.4M |
| ZH Zimmer Holdings, Inc. | 1.5% | Unchanged | 95,500 | $9.8M |
| AP Alexion Pharmaceuticals, Inc. | 1.4% | Unchanged | 49,400 | $9.42M |
| Cvs Health Corporation | 1.4% | Added 75% | 96,200 | $9.41M |
| Ligand Pharmaceuticals Incorporated | 1.3% | Trimmed 15% | 81,640 | $8.85M |
| Incyte Corporation | 1.3% | Added 2.6% | 79,000 | $8.57M |
| Ionis Pharmaceuticals Inc. | 1.3% | New | 138,000 | $8.55M |
| Boston Scientific Corporation | 1.3% | Added 15% | 460,000 | $8.48M |
| Mckesson Corporation | 1.3% | Added 4.9% | 43,000 | $8.48M |
| JP Jazz Pharmaceuticals Public Limited Company | 1.3% | Added 7.1% | 60,000 | $8.43M |
| Vertex Pharmaceuticals Incorporated | 1.3% | Trimmed 19% | 67,000 | $8.43M |
| SJ St. Jude Medical, Inc. | 1.1% | Unchanged | 122,000 | $7.54M |
| CC Cigna Corporation | 1.1% | Trimmed 17% | 48,000 | $7.02M |
| Centene Corporation | 1.1% | Added 428% | 105,630 | $6.95M |
| Biomarin Pharmaceutical Inc. | 1.0% | Unchanged | 65,000 | $6.81M |
| IT Insys Therapeutics, Inc. | 1.0% | Added 10% | 232,000 | $6.64M |
| AC Amerisourcebergen Corporation | 1.0% | Added 6.7% | 64,000 | $6.64M |
| Perrigo Company PLC | 1.0% | Added 10% | 44,000 | $6.37M |
| SP Shire PLC | 1.0% | Trimmed 0.2% | 30,820 | $6.32M |
| Intuitive Surgical, Inc. | 1.0% | Trimmed 15% | 11,550 | $6.31M |
| CB Coherus Biosciences, Inc | 0.9% | Added 12% | 257,000 | $5.9M |
| A Aetna Inc. | 0.9% | Unchanged | 53,000 | $5.73M |
| Halozyme Therapeutics, Inc. | 0.8% | Added 29% | 318,000 | $5.51M |
| Edwards Lifesciences Corporation | 0.8% | Added 55% | 69,000 | $5.45M |
| Humana, Inc. | 0.8% | Unchanged | 30,000 | $5.36M |
| HP Horizon Pharma PLC | 0.8% | Added 11% | 245,000 | $5.31M |
| AP Alkermes Public Limited Company | 0.8% | Added 11% | 65,500 | $5.2M |
| Johnson & Johnson | 0.8% | Unchanged | 50,000 | $5.14M |
| CB C.r. Bard, Inc. | 0.8% | Added 10% | 27,000 | $5.12M |
| MP Mallinckrodt Public Limited Company | 0.8% | Trimmed 15% | 68,000 | $5.08M |
| IE Intersect Ent, Inc. | 0.8% | Added 13% | 225,000 | $5.06M |
| Eagle Pharmaceuticals Inc | 0.7% | New | 55,000 | $4.88M |
| Supernus Pharmaceuticals, Inc. | 0.7% | Added 11% | 355,000 | $4.77M |
| Community Health Systems, Inc. | 0.7% | Added 7.5% | 174,440 | $4.63M |
| AP Achillion Pharmaceuticals, Inc. | 0.7% | Unchanged | 420,000 | $4.53M |
| L Lannett Inc. | 0.7% | New | 107,480 | $4.31M |
| Baxter International Inc. | 0.6% | Added 120% | 110,000 | $4.2M |
| A Anthem, Inc. | 0.6% | Unchanged | 30,000 | $4.18M |
| Bristol-myers Squibb Company | 0.6% | Unchanged | 60,000 | $4.13M |
| HH Hca Holdings, Inc. | 0.6% | Added 50% | 60,000 | $4.06M |
| Neurocrine Biosciences, Inc. | 0.6% | Unchanged | 65,000 | $3.68M |
| Nektar Therapeutics | 0.6% | Trimmed 10% | 216,000 | $3.64M |
| CC Cerner Corporation | 0.6% | Added 9.1% | 60,000 | $3.61M |
| Pfizer Inc. | 0.5% | Added 29% | 110,000 | $3.55M |
Showing top 60 of 127 positions.
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended December 31, 2015 · filed February 12, 2016
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AP Allergan PLC | Exited | −50,150 | −$13.6M | — |
| Ionis Pharmaceuticals Inc. | New | +138,000 | +$8.55M | 1.3% |
| Dr. Reddy's Laboratories Limited | Exited | −130,000 | −$8.31M | — |
| Cardinal Health, Inc. | Added | +91,480 | +$8.17M | 2.3% |
| KP Kite Pharma, Inc. | Trimmed | −105,500 | −$6.5M | 0.1% |
| Centene Corporation | Added | +85,630 | +$5.64M | 1.1% |
| IP Isis Pharmaceuticals, Inc. | Exited | −132,000 | −$5.34M | — |
| M Mylan Inc. | Added | +90,300 | +$4.88M | 2.6% |
| Eagle Pharmaceuticals Inc | New | +55,000 | +$4.88M | 0.7% |
| L Lannett Inc. | New | +107,480 | +$4.31M | 0.7% |
Showing the 10 largest of 88 changes.
quarter ended September 30, 2015 · filed November 12, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| R Receptos, Inc. | Exited | −34,000 | −$6.46M | — |
| Supernus Pharmaceuticals, Inc. | New | +320,000 | +$4.49M | 0.7% |
| Cardinal Health, Inc. | Trimmed | −43,000 | −$3.3M | 1.0% |
| Amgen Inc. | Added | +23,134 | +$3.2M | 2.7% |
| Z Zafgen Inc. | New | +100,000 | +$3.2M | 0.5% |
| KP Kite Pharma, Inc. | Trimmed | −55,500 | −$3.09M | 1.1% |
| AP Alkermes Public Limited Company | Trimmed | −50,500 | −$2.96M | 0.6% |
| IT Insys Therapeutics, Inc. | Added | +90,000 | +$2.56M | 1.0% |
| TC Thoratec Corporation | Exited | −55,000 | −$2.45M | — |
| Incyte Corporation | Added | +20,000 | +$2.21M | 1.4% |
Showing the 10 largest of 108 changes.
quarter ended June 30, 2015 · filed August 12, 2015
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| CC Catamaran Corporation | Exited | −250,440 | −$18.9M | — |
| AP Allergan PLC | New | +49,420 | +$15M | 2.1% |
| AP Actavis PLC | Exited | −48,730 | −$14.5M | — |
| Baxter International Inc. | Exited | −139,500 | −$9.56M | — |
| Centene Corporation | Trimmed | −117,920 | −$9.48M | 0.2% |
| L Lannet, Inc. | Exited | −97,550 | −$6.61M | — |
| Molina Healthcare, Inc. | Exited | −94,960 | −$6.39M | — |
| Illumina, Inc. | Added | +27,180 | +$5.94M | 2.5% |
| Endo International PLC | Added | +72,000 | +$5.73M | 2.1% |
| Acadia Pharmaceuticals Inc. | Trimmed | −130,000 | −$5.44M | 0.6% |
Showing the 10 largest of 114 changes.
Loading...
